Skip to content

Independent service. Not a government website.

FindTendersFindTenders
GoodsMSE preference

INJ BIOVIC 90 MG (SODIUM HYALURONATE),INJ POLATUZUMAB 140MG,Inj Anti-Hemophilic 500 UNIT (Factor-VI

Key dates

  1. Published

    24 Oct 2026, 09:10 AM IST

  2. Bid submission starts

    24 Oct 2026, 09:10 AM IST

  3. Bid submission ends

  4. Bids open

    15 Nov 2026, 10:00 AM IST

Eligibility and documents required

Turnover, experience and document requirements have been read from this tender's documents. Free with an account.

Work description

153 × INJ BIOVIC 90 MG (SODIUM HYALURONATE) , INJ POLATUZUMAB 140MG , Inj Anti-Hemophilic 500 UNIT (Factor-VIII) , INJ ANTI HEMOPHILLIC FACTOR VIII 1000IU , Luspatercept powder for solution for injection 75 mg

Tender documents

  • GEM-2026-B-8078939.pdfGeM bid document

Download documents here with a free account, or from the portal itself. Create free account

Tender details

Tender ID
GEM/2026/B/8078939
Portal
Government e-Marketplace (GeM)
Tender type
GeM Bid
Form of contract
Item wise evaluation
Product category
INJ BIOVIC 90 MG (SODIUM HYALURONATE),INJ POLATUZUMAB 140MG,Inj Anti-Hemophilic 500 UNIT (Factor-VI
INJ BIOVIC 90 MG (SODIUM HYALURONATE),INJ POLATUZUMAB 140MG,Inj Anti-H | FindTenders